LOCALLY ADVANCED BREAST CANCER (LABC)
Clinical trials for LOCALLY ADVANCED BREAST CANCER (LABC) explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED BREAST CANCER (LABC) trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED BREAST CANCER (LABC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune cell combo targets Hard-to-Treat breast cancer
Disease control OngoingThis early-stage trial tests a new two-part treatment for people with advanced breast cancer that has not responded to standard therapies. Participants receive a single infusion of their own engineered immune cells (CLBR001) followed by cycles of a biologic drug (ABBV-461). The m…
Matched conditions: LOCALLY ADVANCED BREAST CANCER (LABC)
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Cancer-Killing virus trial for breast cancer pulled before it started
Disease control TerminatedThis study planned to test a new treatment that uses a modified virus to attack cancer cells, combined with standard pre-surgery therapy, in people with locally advanced breast cancer. The goal was to check safety and find the best dose. However, the study was withdrawn before an…
Matched conditions: LOCALLY ADVANCED BREAST CANCER (LABC)
Phase: PHASE1 • Sponsor: Beijing Bio-Targeting Therapeutics Technology Co., Ltd • Aim: Disease control
Last updated May 05, 2026 11:55 UTC